Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

1,038 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Driving Resilient Supply Chains: Procurement Lessons From India's Pharma Sector

    India's pharmaceutical industry has traditionally been known as the 'pharmacy of the world,' exporting cheap generics and vaccines to the world.
    IndiaGovernment, Public Sector
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    Cipla v Novartis: Import Qualifies As Working Of Patent

    The Indian pharmaceutical industry is a major manufacturer of cost-effective generic drugs and is set to become the leading exporter of generic pharmaceutical products.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
Article

Compulsory Licensing In View Of Pandemic: Bajaj Healthcare Requests For License To Manufacture Baricitinib

Bajaj Healthcare has made a request to the Indian Patent Office for a Compulsory License to manufacture a drug named Baricitinib. The request is made under Section 92 of the Patents Act, 1970...
IndiaIntellectual Property
InvnTree Intellectual Property Services Pvt. Ltd.
InvnTree Intellectual Property Services Pvt. Ltd.
  • Article

    Lee Pharma's Compulsory License Application For Saxagliptin Rejected By Indian Patent Office

    In an order dated 19 January 2016 (Order), the Controller General of Patents and Trademarks rejected the application for Compulsory License for the patent covering AstraZeneca's diabetes management drug Saxagliptin.
    IndiaIntellectual Property
    Khaitan & Co.
    Khaitan & Co.
  • Article

    Pharma Hotline - March 09, 2015

    India's Health Ministry has released a draft of the proposed amendments to the Drugs and Cosmetics Act 1940 (Act) for public consultation.
    IndiaIntellectual Property
    Nishith Desai Associates
    Nishith Desai Associates
  • Article

    Rejections Under Section 3(B) Of The Indian Patent Act

    As per the provision of Section 3 and subsection (b) of the Patent Act, "inventions of primary or intended use or commercial exploitation of which could be contrary to public order or morality...
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    TPM Consultants: March 2026 - Key Highlights

    India and the USA announce framework for Interim Agreement (07 Feb) Earlier this month, India and the USA announced the framework for Interim Agreement regarding reciprocal and mutually beneficial trade.
    IndiaInternational Law
    TPM Solicitors & Consultants
    TPM Solicitors & Consultants
  • Article

    GST Update | Rate Rationalization On Food Products

    Amongst the myriad representations placed before the Goods and Service Tax Council (GST Council) for consideration in their 47th meeting,...
    IndiaTax
    Khaitan & Co.
    Khaitan & Co.
  • Article

    GST Update | Rate Ratıonalization On Food Products

    Amongst the myriad representations placed before the Goods and Service Tax Council (GST Council) for consideration in their 47th meeting,...
    IndiaTax
    Khaitan & Co.
    Khaitan & Co.
  • Article

    BIS Certification Prior To Import Of Drinking Water

    The legislative framework in India aims to ensure standardization based on scientific principles regulating their manufacture, storage, distribution, sale and import of items for safe human consumption.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    CCI Penalises Jalgaon District Medicine Dealers Association And Its Office Bearers For The Imposition Of PIS Charges On Pharmaceutical Companies

    On June 20, 2019, CCI penalised Jalgaon District Medicine Dealers Association (‘JDMDA') as well as its office bearers, i.e., the President and Secretary of JDMDA
    IndiaFood, Drugs, Healthcare, Life Sciences
    AZB & Partners
    AZB & Partners
  • Article

    FSSAI Advisory: E-Commerce Platforms To Properly Categorize Food Products On Their Websites.

    The Food Safety and Standards Authority of India ("FSSAI") is a statutory body established under the Food Safety and Standards Act, 2006 ("FSS Act").
    IndiaFood, Drugs, Healthcare, Life Sciences
    Obhan Mason
    Obhan Mason
  • Article

    NPPA Caps Trade Margin For Six Essential Medical Devices

    Read the latest update authored by our Associate Partner, Pradnesh Warke discussing the recent cap by NPPA on the trade margins of the six essential medical devices.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    US FDA Highlights June 2019

    FDA Finalizes guidance for premarket tobacco product applications to check oversight of tobacco products and health issue
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    WHO Pharma Highlights February 2020 Arnika Sharma

    This segment of the newsletter focusses on sharing the recent regulatory reforms and updates on Healthcare and Pharmaceutical domain from World Health Organization (WHO).
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    AstraZeneca vs. Emcure & MSN: The Conundrum Of Disclosure And Coverage

    The decision in the case of AstraZeneca vs. Emcure and AstraZeneca vs. MSN Labs gave a striking boost to pharmaceuticals industries.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Passing Off Pharmaceutical Products

    Passing off, a form of tort, the substantive law of which is based on common law with the object of protecting some form of property is no where defined in the Trade Marks Act, 1999 though is referred to in ss. 27(2), 134(1)(c) and 135.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    FDA Approval To Larotrectinib Is The First Treatment To Receive A Tumor-Agnostic Indication

    Larotrectinib, is a CNS active TRK inhibitor designed to inhibit these proteins.
    GlobalFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Eco Mark Scheme Under Bureau Of Indian Standards

    ECO Mark Scheme was introduced by the Indian Government for labeling of environment friendly products.
    IndiaEnvironment
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Environmental Impact Of Pharmaceutical Waste: A Review Of The Recent Guidance Document On Disposal Of Expired/ Unused Drugs Issued By CDSCO

    The proper disposal of expired and unused medicines is a critical public health and environmental issue. The recent guidance document issued by the Director General of Health Services, CDSCO, dated 26th May 2025,
    IndiaEnvironment
    IndiaLaw LLP
    IndiaLaw LLP
  • Showing 221–240 of 1038 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics